The U.S. Supreme Court preserved the U.S. Preventative Services Task Force coverage mandate that requires payers to cover certain preventive services at no cost to patients in a 6-3 ruling. That’s ...

By Mariam Sunny and Mrinalika Roy (Reuters) -Shares of Gilead rose 3% after the U.S. Supreme Court on Friday upheld a federal ...

Shares of Gilead Sciences Inc. rallied 2.83% to $110.67 Friday, on what proved to be an all-around great trading session for ...

Bristol Myers (BMY) receives FDA approval for label updates for Breyanzi and Abecma, that can ease access to the cancer cell ...

Yes, the justices upheld a key part of the Affordable Care Act, but they also said our conspiracy theorist Health Secretary ...

The agency removed some onerous requirements for the complex cancer drugs and reduced restrictions on patients’ ...

A new building of condominiums — including three affordable units — has been proposed for Brighton Center. Biotech's Future - ...

Merck announced ACIP voted to recommend Enflosnia (clesrovimab-cfor) as a treatment option for RSV in infants younger than 8 months of age who are born during or entering their first RSV season.

An injection that can prevent HIV infection for six months has been approved by the US Food and Drug Administration (FDA).

Yeztugo (lenacapavir) will be the first option that gives people who need or want PrEP the option of injecting only twice a ...